Precise Identification of Glioblastoma Micro-Infiltration at Cellular Resolution by Raman Spectroscopy

• Published in: Advanced science Vol. 11; no. 36; pp. e2401014 - n/a
• Main Authors: Zhu, Lijun, Li, Jianrui, Pan, Jing, Wu, Nan, Xu, Qing, Zhou, Qing-Qing, Wang, Qiang, Han, Dong, Wang, Ziyang, Xu, Qiang, Liu, Xiaoxue, Guo, Jingxing, Wang, Jiandong, Zhang, Zhiqiang, Wang, Yiqing, Cai, Huiming, Li, Yingjia, Pan, Hao, Zhang, Longjiang, Chen, Xiaoyuan, Lu, Guangming
• Format: Journal Article
• Language: English
• Published: Germany John Wiley & Sons, Inc 01-09-2024; John Wiley and Sons Inc; Wiley
• Subjects: Amino acids; Brain cancer; Brain Neoplasms - metabolism; Brain Neoplasms - pathology; Fatty acids; glioblastoma; Glioblastoma - metabolism; Glioblastoma - pathology; Glioma; Humans; identification; Machine learning; Medical prognosis; Metabolism; Metabolites; micro‐infiltration; Proteins; Raman spectroscopy; Spectrum Analysis, Raman - methods; Tumors; glioblastoma; identification; Raman spectroscopy; micro‐infiltration
• ISSN: 2198-3844; 2198-3844
• DOI: 10.1002/advs.202401014

Precise identification of glioblastoma (GBM) microinfiltration, which is essential for achieving complete resection, remains an enormous challenge in clinical practice. Here, the study demonstrates that Raman spectroscopy effectively identifies GBM microinfiltration with cellular resolution in clinical specimens. The spectral differences between infiltrative lesions and normal brain tissues are attributed to phospholipids, nucleic acids, amino acids, and unsaturated fatty acids. These biochemical metabolites identified by Raman spectroscopy are further confirmed by spatial metabolomics. Based on differential spectra, Raman imaging resolves important morphological information relevant to GBM lesions in a label-free manner. The area under the receiver operating characteristic curve (AUC) for Raman spectroscopy combined with machine learning in detecting infiltrative lesions exceeds 95%. Most importantly, the cancer cell threshold identified by Raman spectroscopy is as low as 3 human GBM cells per 0.01 mm
. Raman spectroscopy enables the detection of previously undetectable diffusely infiltrative cancer cells, which holds potential value in guiding complete tumor resection in GBM patients.